I am a bit jaded when it comes to BP + RAs. This sentence, in particular, does not sit well with me:
Because these treatments are tailored to an individual’s tumour, they pose unique scientific questions on how they should be regulated.
nor does this one:
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer vaccines).
Why mRNA specifically? What 'regulatory guidance'?
Or
The eight-week consultation was launched today and will run until 31 March 2025. The MHRA is asking all stakeholders, including developers of these medicines, to provide comments, after which the guidance will be updated.
I did not find much info on Julian Beach. His bio on MHRA is empty.
Is this yet another attempt to side line NWBO? I've been invested since 2013, I've seen all kinds of attacks on the Company. Maybe I'm reading too much into it. I can't wait for the MHRA approval to put those behind us.